USPH
U.S. Physical Therapy, Inc. NYSE$70.92
After hrs
$71.55
-0.26%
Mkt Cap $1.1B
52w Low $66.67
15.8% of range
52w High $93.50
50d MA $77.14
200d MA $80.60
P/E (TTM)
50.6x
EV/EBITDA
14.4x
P/B
1.4x
Debt/Equity
0.9x
ROE
8.3%
P/FCF
19.4x
RSI (14)
—
ATR (14)
—
Beta
1.35
50d MA
$77.14
200d MA
$80.60
Avg Volume
185.9K
About
U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Se…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 25, 2026 | AMC | 0.67 | 0.67 | +0.0% | 81.68 | -3.0% | -2.9% | +1.6% | +1.7% | +1.9% | +3.0% | — |
| Nov 5, 2025 | AMC | 0.67 | 0.66 | -1.5% | 88.05 | -6.6% | -11.9% | -16.1% | -16.8% | -15.5% | -17.6% | — |
| Aug 6, 2025 | AMC | 0.71 | 0.81 | +14.1% | 72.69 | +9.4% | +15.2% | +20.6% | +19.3% | +20.4% | +21.8% | — |
| May 7, 2025 | AMC | 0.46 | 0.48 | +4.3% | 70.96 | -2.3% | -0.1% | +4.4% | +9.0% | +8.8% | +8.9% | — |
| Feb 26, 2025 | AMC | 0.69 | 0.65 | -5.8% | 87.72 | -6.4% | -6.0% | -7.6% | -9.2% | -9.5% | -7.4% | — |
| Nov 5, 2024 | AMC | 0.68 | 0.69 | +1.5% | 82.53 | +5.9% | +17.7% | +15.4% | +15.2% | +14.6% | +11.6% | — |
| Aug 13, 2024 | AMC | 0.81 | 0.73 | -9.9% | 90.00 | -7.8% | -9.3% | -7.7% | -6.4% | -6.7% | -9.1% | — |
| May 7, 2024 | AMC | 0.56 | 0.51 | -8.9% | 105.59 | -2.8% | -1.6% | -0.5% | +0.8% | -0.6% | +0.8% | — |
| Feb 28, 2024 | AMC | 0.57 | 0.59 | +3.5% | 99.87 | +2.2% | +6.4% | +4.8% | +5.8% | +4.1% | +5.1% | — |
| Nov 7, 2023 | AMC | 0.62 | 0.62 | +0.0% | 85.25 | -5.0% | -2.9% | -5.5% | -3.4% | -3.4% | +2.3% | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 20 | Barrington Research | Maintains | Outperform → Outperform | — | $86.45 | $86.22 | -0.3% | -1.6% | -3.4% | -4.1% | -5.5% | -8.2% |
| Jan 5 | Barrington Research | Maintains | Outperform → Outperform | — | $78.88 | $79.73 | +1.1% | +6.8% | +3.0% | +0.7% | +3.3% | +6.4% |
| Nov 24 | JP Morgan | Maintains | Overweight → Overweight | — | $71.63 | $72.00 | +0.5% | -0.2% | +3.5% | +3.2% | +3.1% | +2.6% |
| Oct 24 | Barrington Research | Maintains | Outperform → Outperform | — | $91.34 | $92.55 | +1.3% | +2.0% | -0.4% | -1.5% | -3.6% | -5.6% |
| Aug 8 | Barrington Research | Maintains | Outperform → Outperform | — | $83.75 | $83.02 | -0.9% | +4.7% | +3.5% | +4.5% | +5.7% | +2.7% |
| Jul 1 | Barrington Research | Maintains | Outperform → Outperform | — | $78.20 | $77.90 | -0.4% | +3.1% | +3.2% | +5.0% | +1.5% | -1.9% |
| Apr 22 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $66.31 | $67.39 | +1.6% | +2.4% | +3.7% | +5.1% | +6.4% | +7.4% |
| Mar 19 | JP Morgan | Maintains | Overweight → Overweight | — | $76.17 | $76.28 | +0.1% | -0.2% | -1.9% | -4.4% | -3.3% | -3.8% |
| Feb 28 | Barrington Research | Maintains | Outperform → Outperform | — | $82.42 | $82.63 | +0.3% | -1.7% | -3.4% | -3.7% | -1.4% | +0.7% |
| Dec 16 | BofA Securities | Upgrade | Neutral → Buy | — | $93.46 | $96.21 | +2.9% | +2.2% | +1.6% | -1.1% | -2.2% | -2.3% |
Recent Filings
— 8-K filing (BAC, USPH)
Apr 15
— 8-K filing (BAC, USPH)
Apr 15
8-K · 1.01
! Medium
Unknown — 8-K 1.01: Financing / Debt Agreement
Bank of America secured $125 million in financing, potentially strengthening liquidity and reducing borrowing costs, which could improve profitability and support shareholder returns.
Apr 15
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
This dividend equivalent structure on restricted stock units protects equity compensation value during vesting periods, but investors should monitor whether excessive RSU grants dilute shareholder ownership and future earnings per share.
Mar 13
8-K · 7.01
! Medium
US Physical Therapy Inc -- 8-K 7.01: Regulation FD Disclosure
US Physical Therapy updated its investor presentation to provide stakeholders with current information about its outpatient clinic operations and industrial injury prevention services business.
Mar 9
8-K · 7.01
! Medium
US Physical Therapy Inc -- 8-K 7.01: Regulation FD Disclosure
US Physical Therapy disclosed 2025 fourth-quarter and full-year financial results via conference call, providing investors with management commentary on operational performance and business outlook.
Mar 3
8-K · 5.02
!!! Very High
US Physical Therapy Inc -- 8-K 5.02: Executive Change
US Physical Therapy Inc (USPH) lost director Carey Hendrickson through resignation, reducing board oversight depth without specified succession details.
Feb 26
8-K · 8.01
!! High
US Physical Therapy Inc -- 8-K 8.01: Material Event / Announcement
US Physical Therapy's Metro Physical Therapy subsidiary established a 10-year strategic alliance with NYU Langone Health to provide physical therapy services across Long Island and the New York metropolitan area, expanding its market reach.
Feb 4
Data updated apr 27, 2026 7:09am
· Source: massive.com